These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28215481)

  • 1. Clinical and histopathological characteristics of patients with prostate cancer in the BioBank Japan project.
    Ukawa S; Nakamura K; Okada E; Hirata M; Nagai A; Yamagata Z; Muto K; Matsuda K; Ninomiya T; Kiyohara Y; Kamatani Y; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S65-S70. PubMed ID: 28215481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of patients with liver cancer in the BioBank Japan project.
    Ukawa S; Okada E; Nakamura K; Hirata M; Nagai A; Matsuda K; Yamagata Z; Kamatani Y; Ninomiya T; Kiyohara Y; Muto K; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S43-S48. PubMed ID: 28214185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project.
    Tamakoshi A; Nakamura K; Ukawa S; Okada E; Hirata M; Nagai A; Matsuda K; Kamatani Y; Muto K; Kiyohara Y; Yamagata Z; Ninomiya T; Kubo M; Nakamura Y;
    J Epidemiol; 2017 Mar; 27(3S):S36-S42. PubMed ID: 28214186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the BioBank Japan Project: Study design and profile.
    Nagai A; Hirata M; Kamatani Y; Muto K; Matsuda K; Kiyohara Y; Ninomiya T; Tamakoshi A; Yamagata Z; Mushiroda T; Murakami Y; Yuji K; Furukawa Y; Zembutsu H; Tanaka T; Ohnishi Y; Nakamura Y; ; Kubo M
    J Epidemiol; 2017 Mar; 27(3S):S2-S8. PubMed ID: 28189464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project.
    Nakamura K; Ukawa S; Okada E; Hirata M; Nagai A; Yamagata Z; Ninomiya T; Muto K; Kiyohara Y; Matsuda K; Kamatani Y; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S49-S57. PubMed ID: 28202209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Risk of Distant Metastases and Cancer Specific Survival in Men with Serum Prostate Specific Antigen Values above 100 ng/ml.
    Stattin K; Sandin F; Bratt O; Lambe M
    J Urol; 2015 Dec; 194(6):1594-600. PubMed ID: 26192253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.
    Klotz L; Vesprini D; Sethukavalan P; Jethava V; Zhang L; Jain S; Yamamoto T; Mamedov A; Loblaw A
    J Clin Oncol; 2015 Jan; 33(3):272-7. PubMed ID: 25512465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies of stage D2 prostatic cancer].
    Amano T; Oshinoya Y; Miyazaki K; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1993 Mar; 39(3):225-9. PubMed ID: 8506794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
    Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
    Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical research on prostate cancer detected in Tone central hospital--comparison of survival rates between patients diagnosed with prostate cancer in and outside screening system].
    Tamur Y; Koya T; Morita T; Kubota Y; Takahashi O; Fujiduka I; Ito K; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 2009 May; 100(4):525-33. PubMed ID: 19514274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL.
    Ang M; Rajcic B; Foreman D; Moretti K; O'Callaghan ME
    BJU Int; 2016 Apr; 117 Suppl 4():68-75. PubMed ID: 26890320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration.
    Shao Q; Ouyang J; Fan Y; Xie J; Zhou J; Wu J; Karim Kader A; Xu J; Liu G; Shan Y; Wen D; Zhang Y
    Cancer Lett; 2012 Feb; 315(2):170-7. PubMed ID: 22099876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the natural history on management of adenocarcinoma of the prostate].
    Schmid HP; Stamey TA; McNeal JE; Freiha FS; Redwine EA; Whittemore AS
    Urologe A; 1994 Mar; 33(2):144-8. PubMed ID: 7513916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of prostate cancer patients in Yokosuka City, Japan: A comparative study between cases detected by prostate-specific antigen-based screening in Yokosuka and those detected by other means.
    Sakai N; Taguri M; Kobayashi K; Noguchi S; Ikeda S; Koh H; Satomi Y; Furuhata A
    Int J Urol; 2015 Aug; 22(8):747-52. PubMed ID: 26011393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
    Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project.
    Nakamura K; Okada E; Ukawa S; Hirata M; Nagai A; Yamagata Z; Kiyohara Y; Muto K; Kamatani Y; Ninomiya T; Matsuda K; Kubo M; Nakamura Y; ; Tamakoshi A
    J Epidemiol; 2017 Mar; 27(3S):S58-S64. PubMed ID: 28223083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
    Kitagawa Y; Namiki M
    Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of BioBank Japan follow-up data in 32 diseases.
    Hirata M; Nagai A; Kamatani Y; Ninomiya T; Tamakoshi A; Yamagata Z; Kubo M; Muto K; Kiyohara Y; Mushiroda T; Murakami Y; Yuji K; Furukawa Y; Zembutsu H; Tanaka T; Ohnishi Y; Nakamura Y; ; Matsuda K
    J Epidemiol; 2017 Mar; 27(3S):S22-S28. PubMed ID: 28190660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme-risk prostate adenocarcinoma presenting with prostate-specific antigen (PSA)>40 ng/ml: prognostic significance of the preradiation PSA nadir.
    Alexander AS; Mydin A; Jones SO; Christie J; Lim JT; Truong PT; Ludgate CM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e713-9. PubMed ID: 21277102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.